[
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are important but seem separate from just mutation and recombination.",
    "rollout": " These are important but seem separate from just mutation and recombination. The main point is that mutations and recombination enhance T-cell function, allowing them to recognize foreign antigens, thus aiding in rejection. So the key here is that during T-cell maturation, mutations cause T-cells to be better at recognizing antigens, leading to rejection. Therefore, option B is the best answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are important but seem separate from just mutation and recombination. The main point is that mutations and recombination enhance T-cell function, allowing them to recognize foreign antigens, thus aiding in rejection. So the key here is that during T-cell maturation, mutations cause T-cells to be better at recognizing antigens, leading to rejection. Therefore, option B is the best answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are all important but aren't directly explaining how mutation and recombination cause rejection.",
    "rollout": " These are all important but aren't directly explaining how mutation and recombination cause rejection. The key part is the interaction between mutations and recombination with T-cell function. So B seems to address how mutations in T-cells improve their ability to recognize foreign antigens, leading to rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are all important but aren't directly explaining how mutation and recombination cause rejection. The key part is the interaction between mutations and recombination with T-cell function. So B seems to address how mutations in T-cells improve their ability to recognize foreign antigens, leading to rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These all relate to how the immune system reacts, but they're more about normal functioning rather than mutation/ recombin.",
    "rollout": " These all relate to how the immune system reacts, but they're more about normal functioning rather than mutation/ recombin. - Option B specifically mentions T-cell maturation and recognition, which directly ties into how the immune system responds after T-cells have developed. So putting it together, option B fits best.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These all relate to how the immune system reacts, but they're more about normal functioning rather than mutation/ recombin. - Option B specifically mentions T-cell maturation and recognition, which directly ties into how the immune system responds after T-cells have developed. So putting it together, option B fits best.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are more about normal functions rather than causing rejection.",
    "rollout": " These are more about normal functions rather than causing rejection. So these aren't directly causing the rejection but just maintaining the immune system's function. Therefore, they're less likely to be the answer here. - Option C says mutation prevents T-cells from recognizing antigens. But if recombination happens, maybe it allows the T-cells to recognize more types. Wait, no\u2014mutation usually affects specific genes, not random mixing. Maybe I was wrong earlier. Alternatively, if the T-cells have mutations that allow them to detect foreign antigens via recombination, then C might be correct. Hmm, this is getting confusing. Let me think again. The main issue is that foreign antigens need to be recognized by T-cells. If mutations cause T-cells to have more antibodies or improve their ability to detect foreign stuff, that would lead to rejection. So option B suggests that during T-cell maturation, mutations result in T-cells that recognize foreign antigens. That makes sense because as T-cells mature, they start responding to various antigens, including foreign ones. If they can't, the body rejects the graft. So B seems correct.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are more about normal functions rather than causing rejection. So these aren't directly causing the rejection but just maintaining the immune system's function. Therefore, they're less likely to be the answer here. - Option C says mutation prevents T-cells from recognizing antigens. But if recombination happens, maybe it allows the T-cells to recognize more types. Wait, no\u2014mutation usually affects specific genes, not random mixing. Maybe I was wrong earlier. Alternatively, if the T-cells have mutations that allow them to detect foreign antigens via recombination, then C might be correct. Hmm, this is getting confusing. Let me think again. The main issue is that foreign antigens need to be recognized by T-cells. If mutations cause T-cells to have more antibodies or improve their ability to detect foreign stuff, that would lead to rejection. So option B suggests that during T-cell maturation, mutations result in T-cells that recognize foreign antigens. That makes sense because as T-cells mature, they start responding to various antigens, including foreign ones. If they can't, the body rejects the graft. So B seems correct.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These seem unrelated to mutation and recombination specifically causing rejection.",
    "rollout": " These seem unrelated to mutation and recombination specifically causing rejection. The main point is about the immune system's ability to recognize foreign antigens after possible mutations through recombination. So B fits best.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These seem unrelated to mutation and recombination specifically causing rejection. The main point is about the immune system's ability to recognize foreign antigens after possible mutations through recombination. So B fits best.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These seem unrelated to the primary mechanism of rejection through mutation and recombination.",
    "rollout": " These seem unrelated to the primary mechanism of rejection through mutation and recombination. - Option B seems most directly related because it explains how T-cells' ability to recognize foreign antigens leads to rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These seem unrelated to the primary mechanism of rejection through mutation and recombination. - Option B seems most directly related because it explains how T-cells' ability to recognize foreign antigens leads to rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are important steps but aren't directly explaining how mutation affects rejection.",
    "rollout": " These are important steps but aren't directly explaining how mutation affects rejection. The key here is about the process itself\u2014how the immune system uses these mutations and recombination to reject the graft. So the main point is that mutations and recombination enhance T-cell recognition, causing them to be rejected. Therefore, option B fits best.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are important steps but aren't directly explaining how mutation affects rejection. The key here is about the process itself\u2014how the immune system uses these mutations and recombination to reject the graft. So the main point is that mutations and recombination enhance T-cell recognition, causing them to be rejected. Therefore, option B fits best.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are more about the mechanisms rather than the direct cause of rejection.",
    "rollout": " These are more about the mechanisms rather than the direct cause of rejection. So they're probably not the main answer here. The key point is whether mutation/ recombin leads to T-cells rejecting foreign antigens. So looking back, option B seems to fit best.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are more about the mechanisms rather than the direct cause of rejection. So they're probably not the main answer here. The key point is whether mutation/ recombin leads to T-cells rejecting foreign antigens. So looking back, option B seems to fit best.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These points are related but seem less directly connected to the specific mechanism of rejecting the graft through mutation and recombination compared to option B.",
    "rollout": " These points are related but seem less directly connected to the specific mechanism of rejecting the graft through mutation and recombination compared to option B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points are related but seem less directly connected to the specific mechanism of rejecting the graft through mutation and recombination compared to option B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are part of the immune system's normal function, but the question specifically asks about mutation and recombination's role.",
    "rollout": " These are part of the immune system's normal function, but the question specifically asks about mutation and recombination's role. So maybe these aren't directly causing rejection but just supporting it. The key here is that mutation and recombination improve T-cell function, not cause rejection themselves. Therefore, the answer should be B because it ties mutation and recombination to improving T-cell function, which leads to foreign antigen recognition and rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are part of the immune system's normal function, but the question specifically asks about mutation and recombination's role. So maybe these aren't directly causing rejection but just supporting it. The key here is that mutation and recombination improve T-cell function, not cause rejection themselves. Therefore, the answer should be B because it ties mutation and recombination to improving T-cell function, which leads to foreign antigen recognition and rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "But the main point here is recombination helping T-cells recognize foreign antigens, which leads to rejection.",
    "rollout": " But the main point here is recombination helping T-cells recognize foreign antigens, which leads to rejection. So B seems like the best answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). But the main point here is recombination helping T-cells recognize foreign antigens, which leads to rejection. So B seems like the best answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These aren't directly about mutation and recombination but rather the mechanisms once the cells are present.",
    "rollout": " These aren't directly about mutation and recombination but rather the mechanisms once the cells are present. So focusing on B seems most relevant.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These aren't directly about mutation and recombination but rather the mechanisms once the cells are present. So focusing on B seems most relevant.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These all seem related but aren't directly about mutation and recombination causing rejection.",
    "rollout": " These all seem related but aren't directly about mutation and recombination causing rejection. The main issue here is how these biological processes interact with the immune system's ability to recognize foreign antigens, which leads to rejection. So the key point is mutation and recombination improving the T-cells' ability to recognize foreign stuff, which causes them to be rejected.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These all seem related but aren't directly about mutation and recombination causing rejection. The main issue here is how these biological processes interact with the immune system's ability to recognize foreign antigens, which leads to rejection. So the key point is mutation and recombination improving the T-cells' ability to recognize foreign stuff, which causes them to be rejected.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These all relate to how T-cells handle foreign antigens.",
    "rollout": " These all relate to how T-cells handle foreign antigens. For example, if a T-cell can't recognize an antigen, it might be degraded or not function properly, leading to rejection. So these options talk about mechanisms that contribute to rejection rather than just mutation and recombination. Therefore, they're less directly related to the cause but part of the process. The main point is that when mutations happen during recombination, T-cells become more sensitive to foreign antigens, causing them to be targeted away, hence rejection. So the best answer would be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These all relate to how T-cells handle foreign antigens. For example, if a T-cell can't recognize an antigen, it might be degraded or not function properly, leading to rejection. So these options talk about mechanisms that contribute to rejection rather than just mutation and recombination. Therefore, they're less directly related to the cause but part of the process. The main point is that when mutations happen during recombination, T-cells become more sensitive to foreign antigens, causing them to be targeted away, hence rejection. So the best answer would be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are important but seem more directly related to the ability to recognize foreign antigens than just mutation and recombination themselves.",
    "rollout": " These are important but seem more directly related to the ability to recognize foreign antigens than just mutation and recombination themselves. The main idea is about how these factors allow T-cells to reactivate or find new targets, which leads to rejection. So the key points are about T-cell function and immune responses, not necessarily the specific mechanisms of mutation and recombination itself.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are important but seem more directly related to the ability to recognize foreign antigens than just mutation and recombination themselves. The main idea is about how these factors allow T-cells to reactivate or find new targets, which leads to rejection. So the key points are about T-cell function and immune responses, not necessarily the specific mechanisms of mutation and recombination itself.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These all relate to how the immune system reacts after the graft is received.",
    "rollout": " These all relate to how the immune system reacts after the graft is received. So I think these aren't directly about mutation and recombination but rather how the body handles the foreign material once it's present. The main point here is whether the initial immune response (mutation and recombination) leads to rejection. So focusing on B makes more sense. It explains how mutations enhance T-cell function against foreign antigens, causing rejection. Therefore, the answer should be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These all relate to how the immune system reacts after the graft is received. So I think these aren't directly about mutation and recombination but rather how the body handles the foreign material once it's present. The main point here is whether the initial immune response (mutation and recombination) leads to rejection. So focusing on B makes more sense. It explains how mutations enhance T-cell function against foreign antigens, causing rejection. Therefore, the answer should be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These all relate to the body's ability to recognize foreign antigens.",
    "rollout": " These all relate to the body's ability to recognize foreign antigens. For example, if the T-cells have identical receptors, they might cause confusion. Similarly, deleting T-cells that can recognize foreign antigens would definitely lead to rejection. So these options are also related but focus on mechanisms rather than direct causes of rejection. The key here is how mutation and recombination specifically enhance T-cell recognition, making them more susceptible to foreign threats. Therefore, option B directly addresses the mechanism causing tissue graft rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These all relate to the body's ability to recognize foreign antigens. For example, if the T-cells have identical receptors, they might cause confusion. Similarly, deleting T-cells that can recognize foreign antigens would definitely lead to rejection. So these options are also related but focus on mechanisms rather than direct causes of rejection. The key here is how mutation and recombination specifically enhance T-cell recognition, making them more susceptible to foreign threats. Therefore, option B directly addresses the mechanism causing tissue graft rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are important but not directly about mutation and recombination contributing to rejection.",
    "rollout": " These are important but not directly about mutation and recombination contributing to rejection. So focusing on B, where mutation leads to T-cells recognizing foreign antigens, would explain why the graft is rejected. Therefore, the answer should be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are important but not directly about mutation and recombination contributing to rejection. So focusing on B, where mutation leads to T-cells recognizing foreign antigens, would explain why the graft is rejected. Therefore, the answer should be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These all tie into how the body's immune system reacts, but I'm not sure how they specifically relate to the initial question about mutation and recombination causing rejection.",
    "rollout": " These all tie into how the body's immune system reacts, but I'm not sure how they specifically relate to the initial question about mutation and recombination causing rejection. The main point is that without proper recognition, the body rejects the graft. So B seems to fit best because it explains how mutations enhance T-cell function in rejecting foreign antigens.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These all tie into how the body's immune system reacts, but I'm not sure how they specifically relate to the initial question about mutation and recombination causing rejection. The main point is that without proper recognition, the body rejects the graft. So B seems to fit best because it explains how mutations enhance T-cell function in rejecting foreign antigens.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are important but seem more specific than what directly ties mutation and recombination to rejection.",
    "rollout": " These are important but seem more specific than what directly ties mutation and recombination to rejection. - Option B fits because mutations during T-cell maturation would enhance T-cells' ability to recognize foreign antigens, causing them to be rejected. So putting it together, the answer should be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are important but seem more specific than what directly ties mutation and recombination to rejection. - Option B fits because mutations during T-cell maturation would enhance T-cells' ability to recognize foreign antigens, causing them to be rejected. So putting it together, the answer should be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are more about how the immune system works rather than directly causing rejection.",
    "rollout": " These are more about how the immune system works rather than directly causing rejection. So B seems more directly related to why the graft is rejected. I also recall that T-cells can be mutated to become more efficient at recognizing antigens, which leads to rejection. So putting it together, option B should be the answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are more about how the immune system works rather than directly causing rejection. So B seems more directly related to why the graft is rejected. I also recall that T-cells can be mutated to become more efficient at recognizing antigens, which leads to rejection. So putting it together, option B should be the answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are important but don't directly explain how mutations and recombination contribute to rejection.",
    "rollout": " These are important but don't directly explain how mutations and recombination contribute to rejection. They're more about the mechanics rather than the mechanism itself. So the key here is understanding that mutations and recombination enhance T-cell function, specifically their ability to recognize foreign antigens, which leads to rejection. Therefore, option B fits best.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are important but don't directly explain how mutations and recombination contribute to rejection. They're more about the mechanics rather than the mechanism itself. So the key here is understanding that mutations and recombination enhance T-cell function, specifically their ability to recognize foreign antigens, which leads to rejection. Therefore, option B fits best.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are more about how the immune system works rather than just mutation and recombination directly causing rejection.",
    "rollout": " These are more about how the immune system works rather than just mutation and recombination directly causing rejection. So the main contribution here must be through mutations and recombination making T-cells better at recognizing foreign antigens. Therefore, the best answer should be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are more about how the immune system works rather than just mutation and recombination directly causing rejection. So the main contribution here must be through mutations and recombination making T-cells better at recognizing foreign antigens. Therefore, the best answer should be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are more about how the immune system works rather than directly contributing to rejection mechanisms.",
    "rollout": " These are more about how the immune system works rather than directly contributing to rejection mechanisms. So these aren't the main points here.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are more about how the immune system works rather than directly contributing to rejection mechanisms. So these aren't the main points here.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "But the main point here is T-cell maturation and their ability to recognize foreign antigens, which aligns with option B.",
    "rollout": " But the main point here is T-cell maturation and their ability to recognize foreign antigens, which aligns with option B. So I think B is the answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). But the main point here is T-cell maturation and their ability to recognize foreign antigens, which aligns with option B. So I think B is the answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These points relate to how the immune system works after a graft is received.",
    "rollout": " These points relate to how the immune system works after a graft is received. For example, if the T-cells aren't able to distinguish self from non-self (option H), they might be rejected. Also, if the immune response to foreign antigens is reduced (F), that would also lead to rejection. So B seems to directly address how mutations during T-cell maturation lead to better recognition, causing rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points relate to how the immune system works after a graft is received. For example, if the T-cells aren't able to distinguish self from non-self (option H), they might be rejected. Also, if the immune response to foreign antigens is reduced (F), that would also lead to rejection. So B seems to directly address how mutations during T-cell maturation lead to better recognition, causing rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are more general aspects and less directly related to how mutations specifically cause rejection compared to B.",
    "rollout": " These are more general aspects and less directly related to how mutations specifically cause rejection compared to B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are more general aspects and less directly related to how mutations specifically cause rejection compared to B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "I think these are important but aren't directly about mutation and recombination.",
    "rollout": " I think these are important but aren't directly about mutation and recombination. The key here is whether mutation affects the ability of T-cells to recognize foreign antigens. So B seems to be the best answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). I think these are important but aren't directly about mutation and recombination. The key here is whether mutation affects the ability of T-cells to recognize foreign antigens. So B seems to be the best answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These factors are part of the immune system's response but aren't directly about how mutation and recombination contribute to rejection.",
    "rollout": " These factors are part of the immune system's response but aren't directly about how mutation and recombination contribute to rejection. So they're less likely to be the answer. The main point here is about the ability of T-cells to recognize foreign antigens, which is best explained by B. So I think B is the correct choice.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These factors are part of the immune system's response but aren't directly about how mutation and recombination contribute to rejection. So they're less likely to be the answer. The main point here is about the ability of T-cells to recognize foreign antigens, which is best explained by B. So I think B is the correct choice.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These don't directly explain how mutations and recombination contribute to rejection.",
    "rollout": " These don't directly explain how mutations and recombination contribute to rejection. - Option B specifically mentions T-cell maturation resulting in cells that recognize foreign antigens, leading to rejection. That fits well. So I think B is the answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These don't directly explain how mutations and recombination contribute to rejection. - Option B specifically mentions T-cell maturation resulting in cells that recognize foreign antigens, leading to rejection. That fits well. So I think B is the answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "But I'm not sure these directly contribute to rejection.",
    "rollout": " But I'm not sure these directly contribute to rejection. The main point is T-cell activity, especially maturation. So B is the best fit.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). But I'm not sure these directly contribute to rejection. The main point is T-cell activity, especially maturation. So B is the best fit.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These points support the idea that mutations allow T-cells to recognize foreign antigens, thus aiding in rejection.",
    "rollout": " These points support the idea that mutations allow T-cells to recognize foreign antigens, thus aiding in rejection. So B and others seem related but focus on specific aspects. The main point here is that mutations enhance T-cell function, allowing them to reject grafts. So among the options, B directly addresses how mutations during T-cell maturation help T-cells recognize foreign antigens, contributing to rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutations allow T-cells to recognize foreign antigens, thus aiding in rejection. So B and others seem related but focus on specific aspects. The main point here is that mutations enhance T-cell function, allowing them to reject grafts. So among the options, B directly addresses how mutations during T-cell maturation help T-cells recognize foreign antigens, contributing to rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are part of the immune system's normal functions, but the question specifically asks about mutation and recombination's effect on rejection.",
    "rollout": " These are part of the immune system's normal functions, but the question specifically asks about mutation and recombination's effect on rejection. So I should focus on what happens when these factors cause issues with T-cell function. The key point is that mutation and recombination in T-cells improve their ability to recognize foreign antigens, leading to rejection. So option B fits best.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are part of the immune system's normal functions, but the question specifically asks about mutation and recombination's effect on rejection. So I should focus on what happens when these factors cause issues with T-cell function. The key point is that mutation and recombination in T-cells improve their ability to recognize foreign antigens, leading to rejection. So option B fits best.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These don't directly address whether mutation and recombination cause rejection, but rather how they work within the system.",
    "rollout": " These don't directly address whether mutation and recombination cause rejection, but rather how they work within the system. So focusing on B seems most accurate. I'm pretty sure B is the answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These don't directly address whether mutation and recombination cause rejection, but rather how they work within the system. So focusing on B seems most accurate. I'm pretty sure B is the answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These points seem more about the mechanisms rather than the cause-effect relation between mutation and recombination and rejection.",
    "rollout": " These points seem more about the mechanisms rather than the cause-effect relation between mutation and recombination and rejection. - Option B specifically mentions T-cell maturation resulting in cells that recognize foreign antigens, directly linking mutation/ Recombination to rejection, which fits my understanding. So I think B is the answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points seem more about the mechanisms rather than the cause-effect relation between mutation and recombination and rejection. - Option B specifically mentions T-cell maturation resulting in cells that recognize foreign antigens, directly linking mutation/ Recombination to rejection, which fits my understanding. So I think B is the answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These would relate more directly to how the immune system works rather than mutation and recombination per se.",
    "rollout": " These would relate more directly to how the immune system works rather than mutation and recombination per se. The main point here is whether these processes contribute to rejecting the graft through mutation and recombination. So, I'm leaning towards option B being the correct answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These would relate more directly to how the immune system works rather than mutation and recombination per se. The main point here is whether these processes contribute to rejecting the graft through mutation and recombination. So, I'm leaning towards option B being the correct answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are more about the mechanics rather than the mechanism itself.",
    "rollout": " These are more about the mechanics rather than the mechanism itself. So B is more about the cause.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are more about the mechanics rather than the mechanism itself. So B is more about the cause.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are part of the immune system's normal functions but don't directly explain how mutation/recombination leads to rejection.",
    "rollout": " These are part of the immune system's normal functions but don't directly explain how mutation/recombination leads to rejection. So B is more about the mechanism within the existing immune system rather than external factors like mutation.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are part of the immune system's normal functions but don't directly explain how mutation/recombination leads to rejection. So B is more about the mechanism within the existing immune system rather than external factors like mutation.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These seem unrelated to the initial question about whether mutation and recombination directly contribute to rejection through their effect on antigen recognition.",
    "rollout": " These seem unrelated to the initial question about whether mutation and recombination directly contribute to rejection through their effect on antigen recognition. - Option F mentions reducing the immune response. While recombination might enhance immune function, I don't see it as causing rejection. - Option G talks about increasing tolerance, but again, this is more about the overall immune system rather than direct involvement in rejecting the graft. - Option H suggests generating T-cells that can't distinguish. That's related to how T-cells work, but it doesn't explain the mechanism of rejection. - Option J is about deleting T-cells that can respond to foreign antigens. That would definitely lead to rejection, but it's more about the outcome than the cause. So putting it together, option B seems to address how mutations during T-cell maturation make T-cells more effective at recognizing foreign antigens, thus contributing to rejection. The others either talk about other mechanisms or unrelated processes.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These seem unrelated to the initial question about whether mutation and recombination directly contribute to rejection through their effect on antigen recognition. - Option F mentions reducing the immune response. While recombination might enhance immune function, I don't see it as causing rejection. - Option G talks about increasing tolerance, but again, this is more about the overall immune system rather than direct involvement in rejecting the graft. - Option H suggests generating T-cells that can't distinguish. That's related to how T-cells work, but it doesn't explain the mechanism of rejection. - Option J is about deleting T-cells that can respond to foreign antigens. That would definitely lead to rejection, but it's more about the outcome than the cause. So putting it together, option B seems to address how mutations during T-cell maturation make T-cells more effective at recognizing foreign antigens, thus contributing to rejection. The others either talk about other mechanisms or unrelated processes.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These seem unrelated to the direct role of mutation and recombination in rejection.",
    "rollout": " These seem unrelated to the direct role of mutation and recombination in rejection. - Option B is more specific and directly ties mutation and recombination to T-cell maturation and cell function.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These seem unrelated to the direct role of mutation and recombination in rejection. - Option B is more specific and directly ties mutation and recombination to T-cell maturation and cell function.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are important but not directly about mutation and recombination.",
    "rollout": " These are important but not directly about mutation and recombination. - Option B specifically mentions T-cell maturation resulting in cells that recognize foreign antigens, which fits because if T-cells aren't good at that, the graft gets rejected. So putting it together, B should be the answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are important but not directly about mutation and recombination. - Option B specifically mentions T-cell maturation resulting in cells that recognize foreign antigens, which fits because if T-cells aren't good at that, the graft gets rejected. So putting it together, B should be the answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These all relate to how the immune system reacts after the graft is received.",
    "rollout": " These all relate to how the immune system reacts after the graft is received. But the main point is about the initial recognition. So B is more directly related to the process before the graft is accepted. It explains why T-cells become more effective at rejecting foreign antigens as they mature.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These all relate to how the immune system reacts after the graft is received. But the main point is about the initial recognition. So B is more directly related to the process before the graft is accepted. It explains why T-cells become more effective at rejecting foreign antigens as they mature.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These all tie into how the body's immune system reacts to foreign antigens.",
    "rollout": " These all tie into how the body's immune system reacts to foreign antigens. But the main point here is how mutation and recombination affect T-cell function, specifically their ability to recognize foreign stuff. So B seems to directly address that. It mentions that mutation and recombination during T-cell maturation cause cells to recognize foreign antigens, contributing to rejection. That fits perfectly.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These all tie into how the body's immune system reacts to foreign antigens. But the main point here is how mutation and recombination affect T-cell function, specifically their ability to recognize foreign stuff. So B seems to directly address that. It mentions that mutation and recombination during T-cell maturation cause cells to recognize foreign antigens, contributing to rejection. That fits perfectly.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "Wait, but these are more about normal functions rather than causing rejection.",
    "rollout": " Wait, but these are more about normal functions rather than causing rejection. So unless the question is about why those processes would cause rejection, they might not be the answer. The key here is that mutation and recombination enhance the ability of T-cells to recognize foreign antigens, leading to rejection. So option B fits.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). Wait, but these are more about normal functions rather than causing rejection. So unless the question is about why those processes would cause rejection, they might not be the answer. The key here is that mutation and recombination enhance the ability of T-cells to recognize foreign antigens, leading to rejection. So option B fits.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are more about how the immune system works rather than just mutation and recombination.",
    "rollout": " These are more about how the immune system works rather than just mutation and recombination. Since the question specifically asks about mutation and recombination, these options aren't directly related. Therefore, B seems to be the best answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are more about how the immune system works rather than just mutation and recombination. Since the question specifically asks about mutation and recombination, these options aren't directly related. Therefore, B seems to be the best answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These all relate to whether the T-cells can handle foreign antigens.",
    "rollout": " These all relate to whether the T-cells can handle foreign antigens. For example, if a T-cell can't differentiate between self and non-self (H), it would be bad because it can't target the foreign material. Similarly, identical receptors (I) might cause issues. - Option B specifically mentions during T-cell maturation resulting in cells that recognize foreign antigens, contributing to rejection. That fits well. Other options either talk about mechanisms that don't directly tie into T-cell maturation or immune response, but B seems most specific and accurate.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These all relate to whether the T-cells can handle foreign antigens. For example, if a T-cell can't differentiate between self and non-self (H), it would be bad because it can't target the foreign material. Similarly, identical receptors (I) might cause issues. - Option B specifically mentions during T-cell maturation resulting in cells that recognize foreign antigens, contributing to rejection. That fits well. Other options either talk about mechanisms that don't directly tie into T-cell maturation or immune response, but B seems most specific and accurate.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are important but not directly about mutation and recombination contributing to rejection.",
    "rollout": " These are important but not directly about mutation and recombination contributing to rejection. - Option B specifically mentions T-cell maturation in the thymus, which is where the T-cells are formed after mutation and recombination. That makes sense because mutations could enhance their ability to recognize foreign antigens once they're in the thymus.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are important but not directly about mutation and recombination contributing to rejection. - Option B specifically mentions T-cell maturation in the thymus, which is where the T-cells are formed after mutation and recombination. That makes sense because mutations could enhance their ability to recognize foreign antigens once they're in the thymus.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These points seem more about how the immune system works rather than direct mutation effects on T-cells.",
    "rollout": " These points seem more about how the immune system works rather than direct mutation effects on T-cells. - Option B directly ties mutation to T-cell function in rejection, which fits the question.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points seem more about how the immune system works rather than direct mutation effects on T-cells. - Option B directly ties mutation to T-cell function in rejection, which fits the question.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These factors either enhance or reduce immune response but don't directly explain how they contribute to rejection.",
    "rollout": " These factors either enhance or reduce immune response but don't directly explain how they contribute to rejection. For example, if a T-cell is made identical, it might have issues rejecting foreign antigens since they're now the same as self. Similarly, deleting T-cells that should handle foreign material would also cause problems. So these options aren't directly addressing how mutation and recombination cause rejection.\n- Option B specifically mentions that mutation and recombination during T-cell maturation result in cells that recognize foreign antigens, contributing to rejection. That fits perfectly because if T-cells can't recognize foreign stuff anymore, they won't attack the foreign material, leading to rejection.\nSo putting it together, the answer should be option B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These factors either enhance or reduce immune response but don't directly explain how they contribute to rejection. For example, if a T-cell is made identical, it might have issues rejecting foreign antigens since they're now the same as self. Similarly, deleting T-cells that should handle foreign material would also cause problems. So these options aren't directly addressing how mutation and recombination cause rejection.\n- Option B specifically mentions that mutation and recombination during T-cell maturation result in cells that recognize foreign antigens, contributing to rejection. That fits perfectly because if T-cells can't recognize foreign stuff anymore, they won't attack the foreign material, leading to rejection.\nSo putting it together, the answer should be option B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are important but seem more detailed than what directly relates to how mutations and recombination cause rejection.",
    "rollout": " These are important but seem more detailed than what directly relates to how mutations and recombination cause rejection. The main point is how mutation and recombination enhance T-cell function. So focusing back on B, it fits best.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are important but seem more detailed than what directly relates to how mutations and recombination cause rejection. The main point is how mutation and recombination enhance T-cell function. So focusing back on B, it fits best.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These points seem related but aren't directly explaining how mutation and recombination cause rejection.",
    "rollout": " These points seem related but aren't directly explaining how mutation and recombination cause rejection. The key here is about the mechanism behind the reactivity of T-cells after being formed. So focusing back on B: mutation and recombination during T-cell maturation in the thymus would result in cells that recognize foreign antigens. That fits because once T-cells mature, mutations could enhance their ability to detect foreign substances, leading to rejection. Therefore, B should be the answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points seem related but aren't directly explaining how mutation and recombination cause rejection. The key here is about the mechanism behind the reactivity of T-cells after being formed. So focusing back on B: mutation and recombination during T-cell maturation in the thymus would result in cells that recognize foreign antigens. That fits because once T-cells mature, mutations could enhance their ability to detect foreign substances, leading to rejection. Therefore, B should be the answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are all related but don't directly address whether mutation and recombination cause rejection.",
    "rollout": " These are all related but don't directly address whether mutation and recombination cause rejection. The key here is understanding how these factors lead to the body rejecting the graft. So focusing back on B, since T-cell maturation in the thymus leads to T-cells that can recognize foreign antigens. That would explain why the graft is rejected.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are all related but don't directly address whether mutation and recombination cause rejection. The key here is understanding how these factors lead to the body rejecting the graft. So focusing back on B, since T-cell maturation in the thymus leads to T-cells that can recognize foreign antigens. That would explain why the graft is rejected.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "Wait, but the main issue here is whether these factors contribute to rejection.",
    "rollout": " Wait, but the main issue here is whether these factors contribute to rejection. So perhaps C, D, E, F, G, H, J relate to mechanisms that cause rejection rather than being causes themselves. - Option B mentions that mutations during T-cell maturation lead to cells that recognize foreign antigens, contributing to rejection. That fits because if T-cells can't recognize foreign stuff, they'd be targeted instead of rejecting the graft.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). Wait, but the main issue here is whether these factors contribute to rejection. So perhaps C, D, E, F, G, H, J relate to mechanisms that cause rejection rather than being causes themselves. - Option B mentions that mutations during T-cell maturation lead to cells that recognize foreign antigens, contributing to rejection. That fits because if T-cells can't recognize foreign stuff, they'd be targeted instead of rejecting the graft.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These points relate to why the graft is accepted\u2014because the body recognizes foreign threats.",
    "rollout": " These points relate to why the graft is accepted\u2014because the body recognizes foreign threats. However, the main point here is how mutation and recombination specifically affect T-cell function. So while some of these options are important, the primary answer should be about T-cell maturation and their ability to recognize foreign antigens.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points relate to why the graft is accepted\u2014because the body recognizes foreign threats. However, the main point here is how mutation and recombination specifically affect T-cell function. So while some of these options are important, the primary answer should be about T-cell maturation and their ability to recognize foreign antigens.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These factors definitely relate to how the immune system reacts.",
    "rollout": " These factors definitely relate to how the immune system reacts. For example, if a T-cell can't differentiate between self and non-self, it might not be effective against foreign antigens. So these options are important but perhaps aren't directly about mutation and recombination causing rejection. The main point is that when T-cells can't recognize foreign antigens, they're rejected. So looking back, option B seems to fit because mutations allow T-cells to recognize foreign antigens, leading to rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These factors definitely relate to how the immune system reacts. For example, if a T-cell can't differentiate between self and non-self, it might not be effective against foreign antigens. So these options are important but perhaps aren't directly about mutation and recombination causing rejection. The main point is that when T-cells can't recognize foreign antigens, they're rejected. So looking back, option B seems to fit because mutations allow T-cells to recognize foreign antigens, leading to rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "But these seem more about normal functions rather than contributing to rejection specifically.",
    "rollout": " But these seem more about normal functions rather than contributing to rejection specifically. The key point here is how mutation and recombination cause T-cells to miss foreign antigens, leading to rejection. So B fits best.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). But these seem more about normal functions rather than contributing to rejection specifically. The key point here is how mutation and recombination cause T-cells to miss foreign antigens, leading to rejection. So B fits best.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These relate to how the immune system works after a graft is received.",
    "rollout": " These relate to how the immune system works after a graft is received. For example, if an organ is replaced, the immune system has to adapt. So these processes would prevent rejection instead of helping. Therefore, B seems to directly address how mutation and recombination help the immune system recognize foreign antigens, causing rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These relate to how the immune system works after a graft is received. For example, if an organ is replaced, the immune system has to adapt. So these processes would prevent rejection instead of helping. Therefore, B seems to directly address how mutation and recombination help the immune system recognize foreign antigens, causing rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These points support that mutations enhance T-cell function, which leads to rejection.",
    "rollout": " These points support that mutations enhance T-cell function, which leads to rejection. For example, if T-cells aren't as good at recognizing foreign antigens, they'll be targeted more, causing rejection. So option B seems to fit best because it directly links mutation and recombination to T-cell maturation and foreign antigen recognition, thus contributing to rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support that mutations enhance T-cell function, which leads to rejection. For example, if T-cells aren't as good at recognizing foreign antigens, they'll be targeted more, causing rejection. So option B seems to fit best because it directly links mutation and recombination to T-cell maturation and foreign antigen recognition, thus contributing to rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These seem unrelated to whether mutation and recombination cause rejection but rather how the immune system works.",
    "rollout": " These seem unrelated to whether mutation and recombination cause rejection but rather how the immune system works. So probably not these. - Option B seems to connect mutation and recombination directly to T-cell activity and rejection, which fits what I was thinking earlier.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These seem unrelated to whether mutation and recombination cause rejection but rather how the immune system works. So probably not these. - Option B seems to connect mutation and recombination directly to T-cell activity and rejection, which fits what I was thinking earlier.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These seem related but aren't directly explaining the mechanism of rejection through mutation/recombination as clearly as option B.",
    "rollout": " These seem related but aren't directly explaining the mechanism of rejection through mutation/recombination as clearly as option B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These seem related but aren't directly explaining the mechanism of rejection through mutation/recombination as clearly as option B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These points seem more related to how the immune system works rather than just mutation and recombination per se.",
    "rollout": " These points seem more related to how the immune system works rather than just mutation and recombination per se. They're about the broader mechanisms of the immune response rather than individual mutations causing specific immune reactions. So I'm leaning towards option B being the answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points seem more related to how the immune system works rather than just mutation and recombination per se. They're about the broader mechanisms of the immune response rather than individual mutations causing specific immune reactions. So I'm leaning towards option B being the answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "But the main point here is about how mutation affects T-cell function.",
    "rollout": " But the main point here is about how mutation affects T-cell function. So focusing on B would be better. I think B explains how mutations enhance T-cell function against foreign antigens, leading to rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). But the main point here is about how mutation affects T-cell function. So focusing on B would be better. I think B explains how mutations enhance T-cell function against foreign antigens, leading to rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are all about how the immune system handles foreign antigens.",
    "rollout": " These are all about how the immune system handles foreign antigens. If the immune system doesn't recognize them, those processes would contribute to rejection. So both B and others deal with the same concept but perhaps in different ways. The key point is that mutations and recombination improve the T-cells' ability to recognize foreign antigens, leading to rejection. Therefore, the most accurate answer should be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are all about how the immune system handles foreign antigens. If the immune system doesn't recognize them, those processes would contribute to rejection. So both B and others deal with the same concept but perhaps in different ways. The key point is that mutations and recombination improve the T-cells' ability to recognize foreign antigens, leading to rejection. Therefore, the most accurate answer should be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These seem related but aren't directly explaining how mutation and recombination cause rejection.",
    "rollout": " These seem related but aren't directly explaining how mutation and recombination cause rejection. The key point is T-cell activity, specifically their ability to recognize foreign antigens. So the most direct answer would be option B. It explains that mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These seem related but aren't directly explaining how mutation and recombination cause rejection. The key point is T-cell activity, specifically their ability to recognize foreign antigens. So the most direct answer would be option B. It explains that mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These relate to the immune system's ability to handle foreign antigens.",
    "rollout": " These relate to the immune system's ability to handle foreign antigens. But the question specifically asks about mutation and recombination. The key here is whether these genetic changes enhance or impair T-cell function. Since mutation and recombination are part of what makes T-cells recognize foreign antigens better, especially after T-cell maturation, B seems to fit.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These relate to the immune system's ability to handle foreign antigens. But the question specifically asks about mutation and recombination. The key here is whether these genetic changes enhance or impair T-cell function. Since mutation and recombination are part of what makes T-cells recognize foreign antigens better, especially after T-cell maturation, B seems to fit.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These don't directly explain how mutation and recombination cause rejection but rather aspects of the immune response.",
    "rollout": " These don't directly explain how mutation and recombination cause rejection but rather aspects of the immune response. So focusing on B seems more accurate.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These don't directly explain how mutation and recombination cause rejection but rather aspects of the immune response. So focusing on B seems more accurate.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "I recall that T-cells have surface receptors; mutations can cause these to change, but I'm not sure how that directly contributes to rejection.",
    "rollout": " I recall that T-cells have surface receptors; mutations can cause these to change, but I'm not sure how that directly contributes to rejection. Maybe it affects immune tolerance instead? Wait, option G mentions increasing tolerance, which would mean the body is more likely to accept the graft. That contradicts rejection. Hmm. - Option H suggests generating T-cells that can't distinguish between self and non-self. That sounds like they'd be bad at rejecting foreign antigens, which fits with rejection. So H might also be correct. But I need to decide which one is the best answer. The question asks which of the statements correctly describe how mutation and recombination contribute to rejection. Both B and H seem plausible. Wait, let me go back. Option B states that mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens. That makes sense because as T-cells mature, they might start recognizing foreign substances, leading to rejection. Option H says mutation and recombination generate T-cells that can't differentiate between self and non-self. That's another way to see it\u2014they become ineffective at distinguishing, so they're worse at rejecting. Which one is the answer? Both B and H seem correct, but looking at the structure of the options, perhaps B is more about the mechanism after T-cell maturation, while H is more about the overall effect on cell function. Alternatively, perhaps both are correct, but since it's multiple-choice, maybe only one is intended. Alternatively, maybe the correct answer is B because it specifically refers to T-cell maturation. Or perhaps both B and H are correct, but in the given context, the user expects a single letter answer. Since the options are separate, perhaps the intended answer is B because it's about the specific event during T-cell maturation.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). I recall that T-cells have surface receptors; mutations can cause these to change, but I'm not sure how that directly contributes to rejection. Maybe it affects immune tolerance instead? Wait, option G mentions increasing tolerance, which would mean the body is more likely to accept the graft. That contradicts rejection. Hmm. - Option H suggests generating T-cells that can't distinguish between self and non-self. That sounds like they'd be bad at rejecting foreign antigens, which fits with rejection. So H might also be correct. But I need to decide which one is the best answer. The question asks which of the statements correctly describe how mutation and recombination contribute to rejection. Both B and H seem plausible. Wait, let me go back. Option B states that mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens. That makes sense because as T-cells mature, they might start recognizing foreign substances, leading to rejection. Option H says mutation and recombination generate T-cells that can't differentiate between self and non-self. That's another way to see it\u2014they become ineffective at distinguishing, so they're worse at rejecting. Which one is the answer? Both B and H seem correct, but looking at the structure of the options, perhaps B is more about the mechanism after T-cell maturation, while H is more about the overall effect on cell function. Alternatively, perhaps both are correct, but since it's multiple-choice, maybe only one is intended. Alternatively, maybe the correct answer is B because it specifically refers to T-cell maturation. Or perhaps both B and H are correct, but in the given context, the user expects a single letter answer. Since the options are separate, perhaps the intended answer is B because it's about the specific event during T-cell maturation.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "Wait, but the main point is about recombination and mutation contributing to rejection.",
    "rollout": " Wait, but the main point is about recombination and mutation contributing to rejection. So focusing back on B and others. - Option B specifically mentions T-cell maturation in the thymus resulting in cells that recognize foreign antigens. That fits well because once T-cells mature, they're ready to reactivate and take up foreign stuff, leading to rejection. The rest seem to be either unrelated or incorrect. So I think the answer is B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). Wait, but the main point is about recombination and mutation contributing to rejection. So focusing back on B and others. - Option B specifically mentions T-cell maturation in the thymus resulting in cells that recognize foreign antigens. That fits well because once T-cells mature, they're ready to reactivate and take up foreign stuff, leading to rejection. The rest seem to be either unrelated or incorrect. So I think the answer is B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These all relate to how the immune system works, but I'm not sure how they specifically tie into graft rejection beyond general immune function.",
    "rollout": " These all relate to how the immune system works, but I'm not sure how they specifically tie into graft rejection beyond general immune function. - Option B fits better because it directly connects mutation and recombination during T-cell maturation to cell recognition and rejection. The other options either discuss unrelated processes or incorrect mechanisms.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These all relate to how the immune system works, but I'm not sure how they specifically tie into graft rejection beyond general immune function. - Option B fits better because it directly connects mutation and recombination during T-cell maturation to cell recognition and rejection. The other options either discuss unrelated processes or incorrect mechanisms.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These seem less directly related to mutation and recombination causing rejection compared to B.",
    "rollout": " These seem less directly related to mutation and recombination causing rejection compared to B. So I'm leaning towards B being the answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These seem less directly related to mutation and recombination causing rejection compared to B. So I'm leaning towards B being the answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are more general aspects but related to how the immune system works.",
    "rollout": " These are more general aspects but related to how the immune system works. However, the question specifically asks about mutation and recombination contributing to rejection, so these might be secondary effects rather than direct contributors. - Option B directly links mutation and recombination to T-cell maturation and foreign recognition, which aligns with what I know about T-cell-mediated reactions leading to graft rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are more general aspects but related to how the immune system works. However, the question specifically asks about mutation and recombination contributing to rejection, so these might be secondary effects rather than direct contributors. - Option B directly links mutation and recombination to T-cell maturation and foreign recognition, which aligns with what I know about T-cell-mediated reactions leading to graft rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These all tie into whether the immune system can recognize foreign antigens.",
    "rollout": " These all tie into whether the immune system can recognize foreign antigens. Since the question is about why graft rejection happens due to mutation and recombination, B seems most directly related because it explains how T-cells' abilities change, leading to rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These all tie into whether the immune system can recognize foreign antigens. Since the question is about why graft rejection happens due to mutation and recombination, B seems most directly related because it explains how T-cells' abilities change, leading to rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These points seem related but aren't directly explaining how mutation and recombination cause rejection.",
    "rollout": " These points seem related but aren't directly explaining how mutation and recombination cause rejection. The key here is understanding that T-cells must recognize foreign antigens to reject the graft. So the most direct answer would be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points seem related but aren't directly explaining how mutation and recombination cause rejection. The key here is understanding that T-cells must recognize foreign antigens to reject the graft. So the most direct answer would be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "But the main point here is about T-cell activity leading to rejection.",
    "rollout": " But the main point here is about T-cell activity leading to rejection. So focusing on B would be key.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). But the main point here is about T-cell activity leading to rejection. So focusing on B would be key.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "But the main point here is whether mutation/rec combines to cause rejection.",
    "rollout": " But the main point here is whether mutation/rec combines to cause rejection. I think B covers T-cell maturation and their function in rejecting grafts.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). But the main point here is whether mutation/rec combines to cause rejection. I think B covers T-cell maturation and their function in rejecting grafts.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are all related but aren't directly explaining how mutation and recombination contribute to rejection.",
    "rollout": " These are all related but aren't directly explaining how mutation and recombination contribute to rejection. For example, repair would be part of the immune response, not necessarily causing rejection. Similarly, generating T-cells that can't distinguish (H) might cause issues, but I'm not sure if that's specifically about mutation and recombination. So focusing back on the main points: T-cells need to recognize antigens. If mutation causes recombination (like mixing DNA), they become more efficient at doing that. So option B fits.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are all related but aren't directly explaining how mutation and recombination contribute to rejection. For example, repair would be part of the immune response, not necessarily causing rejection. Similarly, generating T-cells that can't distinguish (H) might cause issues, but I'm not sure if that's specifically about mutation and recombination. So focusing back on the main points: T-cells need to recognize antigens. If mutation causes recombination (like mixing DNA), they become more efficient at doing that. So option B fits.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "Wait, but the main point here is whether these processes contribute to rejection.",
    "rollout": " Wait, but the main point here is whether these processes contribute to rejection. I think if T-cells can't recognize foreign antigens, they would be rejected, so C and others might relate. However, the question specifically asks about mutation and recombination's role, so focusing on those. Between B and C, B seems more directly related to the mechanism of recombination affecting T-cell function in rejection. So I'll go with B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). Wait, but the main point here is whether these processes contribute to rejection. I think if T-cells can't recognize foreign antigens, they would be rejected, so C and others might relate. However, the question specifically asks about mutation and recombination's role, so focusing on those. Between B and C, B seems more directly related to the mechanism of recombination affecting T-cell function in rejection. So I'll go with B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These points relate to why the graft might be accepted or rejected based on immune function.",
    "rollout": " These points relate to why the graft might be accepted or rejected based on immune function. However, the direct link between mutation and recombination and graft rejection is more about T-cell function than just repair processes. So while these options are important, they're secondary to the primary issue here. The main point is that mutations and recombination enhance T-cell function, specifically improving their ability to recognize foreign antigens, thus contributing to rejection. Therefore, the best answer should be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points relate to why the graft might be accepted or rejected based on immune function. However, the direct link between mutation and recombination and graft rejection is more about T-cell function than just repair processes. So while these options are important, they're secondary to the primary issue here. The main point is that mutations and recombination enhance T-cell function, specifically improving their ability to recognize foreign antigens, thus contributing to rejection. Therefore, the best answer should be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These all tie into how the immune system reacts to foreign antigens.",
    "rollout": " These all tie into how the immune system reacts to foreign antigens. However, the question specifically asks about mutation and recombination contributing to rejection, so focusing on these would be better. Between B and others, B directly relates to T-cell maturation and their ability to recognize foreign antigens, which leads to rejection. The other options either discuss mechanisms without tying to the specific cause of rejection mentioned here.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These all tie into how the immune system reacts to foreign antigens. However, the question specifically asks about mutation and recombination contributing to rejection, so focusing on these would be better. Between B and others, B directly relates to T-cell maturation and their ability to recognize foreign antigens, which leads to rejection. The other options either discuss mechanisms without tying to the specific cause of rejection mentioned here.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are part of the immune system's normal functions but aren't directly causing rejection.",
    "rollout": " These are part of the immune system's normal functions but aren't directly causing rejection. So unless mutation affects those, they wouldn't cause rejection. The main driver here would be the ability of T-cells to recognize antigens, which comes from mutations and recombination in the T-cells themselves. So B looks best.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are part of the immune system's normal functions but aren't directly causing rejection. So unless mutation affects those, they wouldn't cause rejection. The main driver here would be the ability of T-cells to recognize antigens, which comes from mutations and recombination in the T-cells themselves. So B looks best.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These would relate to why the graft is accepted\u2014like if the immune system is weak against foreign antigens, but also if the T-cells can't handle them.",
    "rollout": " These would relate to why the graft is accepted\u2014like if the immune system is weak against foreign antigens, but also if the T-cells can't handle them. However, the question specifically asks about mutation and recombination contributing to rejection. So options B and H talk about how mutations can lead to better or worse recognition. For example, if mutations enhance T-cell recognition, then they're more likely to reject the graft. If they cause issues, perhaps the T-cells don't recognize them as well. So both B and H seem possible. Wait, the original answer was B, but let me double-check. The initial thought was B, but now I'm second-guessing because I'm thinking about how mutations in T-cells can either help or hinder their ability to recognize foreign antigens. So if mutations improve T-cell function, they'll be more effective at rejecting the graft, meaning less tolerance. Conversely, if mutations impair recognition, the T-cells won't handle foreign materials as well, leading to more tolerance. So mutation and recombination can either aid or hinder this process depending on what happens. Therefore, the correct statement should reflect that mutation and recombination can contribute to either enhancing or impairing immune tolerance towards foreign antigens, thus influencing whether the graft is accepted or rejected.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These would relate to why the graft is accepted\u2014like if the immune system is weak against foreign antigens, but also if the T-cells can't handle them. However, the question specifically asks about mutation and recombination contributing to rejection. So options B and H talk about how mutations can lead to better or worse recognition. For example, if mutations enhance T-cell recognition, then they're more likely to reject the graft. If they cause issues, perhaps the T-cells don't recognize them as well. So both B and H seem possible. Wait, the original answer was B, but let me double-check. The initial thought was B, but now I'm second-guessing because I'm thinking about how mutations in T-cells can either help or hinder their ability to recognize foreign antigens. So if mutations improve T-cell function, they'll be more effective at rejecting the graft, meaning less tolerance. Conversely, if mutations impair recognition, the T-cells won't handle foreign materials as well, leading to more tolerance. So mutation and recombination can either aid or hinder this process depending on what happens. Therefore, the correct statement should reflect that mutation and recombination can contribute to either enhancing or impairing immune tolerance towards foreign antigens, thus influencing whether the graft is accepted or rejected.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These would relate to why the graft is accepted\u2014like if the immune system doesn't attack it enough, causing rejection.",
    "rollout": " These would relate to why the graft is accepted\u2014like if the immune system doesn't attack it enough, causing rejection. But the question specifically asks about mutation and recombination contributing to rejection, so focusing on processes related to immune detection. Between B and others, B directly ties mutation and recombination to T-cell function, which impacts rejection. So I'll go with B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These would relate to why the graft is accepted\u2014like if the immune system doesn't attack it enough, causing rejection. But the question specifically asks about mutation and recombination contributing to rejection, so focusing on processes related to immune detection. Between B and others, B directly ties mutation and recombination to T-cell function, which impacts rejection. So I'll go with B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These all relate to how the immune system reacts after a graft is given.",
    "rollout": " These all relate to how the immune system reacts after a graft is given. For example, if the T-cells can't recognize foreign antigens, they won't attack the graft, reducing the immune response. So B and J might be related but separate. C suggests mutation prevents recognition, which would support J. Wait, no, C says mutation and recombination prevent recognition, which is what leads to J where T-cells delete them. So both B and C are possible. But looking back, the question asks how mutation and recombination contribute to rejection. So recombination would mix genetic info, potentially increasing the chance of cells recognizing foreign antigens, which would directly cause rejection. So B is saying that during T-cell maturation, mutations in T-cells result in them recognizing foreign antigens. That fits because as T-cells mature, they start responding to antigens, even foreign ones. So B would be correct. Also, J says mutations lead to T-cells deleting themselves from foreign antigens. That's another way to look at it\u2014mutation leads to defective T-cells that can't handle foreign stuff, so they're deleted. So B and J are both plausible. But the question is asking for the step, so perhaps focusing on T-cell maturation causing recognition.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These all relate to how the immune system reacts after a graft is given. For example, if the T-cells can't recognize foreign antigens, they won't attack the graft, reducing the immune response. So B and J might be related but separate. C suggests mutation prevents recognition, which would support J. Wait, no, C says mutation and recombination prevent recognition, which is what leads to J where T-cells delete them. So both B and C are possible. But looking back, the question asks how mutation and recombination contribute to rejection. So recombination would mix genetic info, potentially increasing the chance of cells recognizing foreign antigens, which would directly cause rejection. So B is saying that during T-cell maturation, mutations in T-cells result in them recognizing foreign antigens. That fits because as T-cells mature, they start responding to antigens, even foreign ones. So B would be correct. Also, J says mutations lead to T-cells deleting themselves from foreign antigens. That's another way to look at it\u2014mutation leads to defective T-cells that can't handle foreign stuff, so they're deleted. So B and J are both plausible. But the question is asking for the step, so perhaps focusing on T-cell maturation causing recognition.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These factors definitely relate to how the immune system reacts, but the main contribution here is how mutations and recombination influence this reaction, particularly in T-cells.",
    "rollout": " These factors definitely relate to how the immune system reacts, but the main contribution here is how mutations and recombination influence this reaction, particularly in T-cells. So B seems to be the best answer because it directly links mutation/ recombinase activity to T-cell maturation and immune rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These factors definitely relate to how the immune system reacts, but the main contribution here is how mutations and recombination influence this reaction, particularly in T-cells. So B seems to be the best answer because it directly links mutation/ recombinase activity to T-cell maturation and immune rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are more about how the immune system works rather than just mutation and recombination themselves.",
    "rollout": " These are more about how the immune system works rather than just mutation and recombination themselves. So unless these options directly link mutation and recombination to T-cell function, they're less likely. - Option B specifically mentions T-cell maturation in the thymus resulting in cells that recognize foreign antigens, which aligns perfectly with the scenario described. Therefore, B seems the best answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are more about how the immune system works rather than just mutation and recombination themselves. So unless these options directly link mutation and recombination to T-cell function, they're less likely. - Option B specifically mentions T-cell maturation in the thymus resulting in cells that recognize foreign antigens, which aligns perfectly with the scenario described. Therefore, B seems the best answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These relate to the body's ability to recognize and fight foreign threats, but they're more general than just mutation and recombination specifically affecting T-cell function.",
    "rollout": " These relate to the body's ability to recognize and fight foreign threats, but they're more general than just mutation and recombination specifically affecting T-cell function. The question is asking about how these factors directly contribute to rejection, so I need something focused on T-cell activities. - Option B seems to tie mutation and recombination to T-cell activity, making them recognize foreign antigens, which leads to rejection. So putting it together, B should be the answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These relate to the body's ability to recognize and fight foreign threats, but they're more general than just mutation and recombination specifically affecting T-cell function. The question is asking about how these factors directly contribute to rejection, so I need something focused on T-cell activities. - Option B seems to tie mutation and recombination to T-cell activity, making them recognize foreign antigens, which leads to rejection. So putting it together, B should be the answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are all related to how the immune system works, but they're more about how the body handles the foreign antigen rather than directly causing rejection.",
    "rollout": " These are all related to how the immune system works, but they're more about how the body handles the foreign antigen rather than directly causing rejection. - Option B specifically mentions T-cell maturation resulting in cells that recognize foreign antigens, which fits because once T-cells mature, they become more active in attacking the foreign material, leading to rejection. So putting it together, B seems to be the best answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are all related to how the immune system works, but they're more about how the body handles the foreign antigen rather than directly causing rejection. - Option B specifically mentions T-cell maturation resulting in cells that recognize foreign antigens, which fits because once T-cells mature, they become more active in attacking the foreign material, leading to rejection. So putting it together, B seems to be the best answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "But the main point here is whether these factors directly cause rejection.",
    "rollout": " But the main point here is whether these factors directly cause rejection. So B seems to address T-cell maturation leading to resistance. It also explains that mutations during this process improve antigen recognition, aiding in rejection. So putting it together, option B should be the answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). But the main point here is whether these factors directly cause rejection. So B seems to address T-cell maturation leading to resistance. It also explains that mutations during this process improve antigen recognition, aiding in rejection. So putting it together, option B should be the answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These factors are part of the immune system's function but aren't directly causing or contributing to graft rejection.",
    "rollout": " These factors are part of the immune system's function but aren't directly causing or contributing to graft rejection. So they're less likely to be the main contributors. Therefore, B seems to be the best answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These factors are part of the immune system's function but aren't directly causing or contributing to graft rejection. So they're less likely to be the main contributors. Therefore, B seems to be the best answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These seem unrelated to the direct role of mutation and recombination in rejecting the graft, unless they're part of the overall immune response.",
    "rollout": " These seem unrelated to the direct role of mutation and recombination in rejecting the graft, unless they're part of the overall immune response. But since the question specifically asks about how these mutations and recombination contribute directly to tissue rejection, I think B is the best choice.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These seem unrelated to the direct role of mutation and recombination in rejecting the graft, unless they're part of the overall immune response. But since the question specifically asks about how these mutations and recombination contribute directly to tissue rejection, I think B is the best choice.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are more about how the immune system works rather than directly causing rejection.",
    "rollout": " These are more about how the immune system works rather than directly causing rejection. So unless the question is about mechanisms within the immune response itself, these options aren't directly about rejection. The key here must be about how T-cells' ability to recognize foreign antigens affects rejection. \n\nSo putting it together, option B states that mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection. That fits because if the T-cells don't recognize foreign stuff, they'll go after other issues first.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are more about how the immune system works rather than directly causing rejection. So unless the question is about mechanisms within the immune response itself, these options aren't directly about rejection. The key here must be about how T-cells' ability to recognize foreign antigens affects rejection. \n\nSo putting it together, option B states that mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection. That fits because if the T-cells don't recognize foreign stuff, they'll go after other issues first.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are important steps but not directly about mutation and recombination contributing to rejection.",
    "rollout": " These are important steps but not directly about mutation and recombination contributing to rejection. The key here is the interaction between mutation and recombination with T-cell function. So B seems to fit best.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are important steps but not directly about mutation and recombination contributing to rejection. The key here is the interaction between mutation and recombination with T-cell function. So B seems to fit best.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These all relate to how the immune system reacts.",
    "rollout": " These all relate to how the immune system reacts. But the main point here is about mutation and recombination leading to better recognition. So C says they prevent recognition, but that wouldn't lead to rejection; instead, it would help. Therefore, C is incorrect. - Option B seems to directly link mutation and recombination to T-cell maturation and foreign antigen recognition, which aligns with the problem statement.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These all relate to how the immune system reacts. But the main point here is about mutation and recombination leading to better recognition. So C says they prevent recognition, but that wouldn't lead to rejection; instead, it would help. Therefore, C is incorrect. - Option B seems to directly link mutation and recombination to T-cell maturation and foreign antigen recognition, which aligns with the problem statement.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These relate more to how the immune system works rather than just mutation and recombination themselves.",
    "rollout": " These relate more to how the immune system works rather than just mutation and recombination themselves. So they're less directly related to the main cause of rejection. Therefore, the most accurate answer should be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These relate more to how the immune system works rather than just mutation and recombination themselves. So they're less directly related to the main cause of rejection. Therefore, the most accurate answer should be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These all tie into how the immune system reacts, but they're more specific than just mutation and recombination.",
    "rollout": " These all tie into how the immune system reacts, but they're more specific than just mutation and recombination. The main point here is how these factors affect T-cell function, which directly impacts graft rejection through T-cell-mediated attacks.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These all tie into how the immune system reacts, but they're more specific than just mutation and recombination. The main point here is how these factors affect T-cell function, which directly impacts graft rejection through T-cell-mediated attacks.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These seem unrelated unless they're part of the mechanism behind rejection, but I'm not sure.",
    "rollout": " These seem unrelated unless they're part of the mechanism behind rejection, but I'm not sure. The main point is whether mutation and recombination directly cause T-cells to recognize foreign antigens. I think B is the best answer because it specifically mentions T-cell maturation in the thymus where mutations could enhance recognition.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These seem unrelated unless they're part of the mechanism behind rejection, but I'm not sure. The main point is whether mutation and recombination directly cause T-cells to recognize foreign antigens. I think B is the best answer because it specifically mentions T-cell maturation in the thymus where mutations could enhance recognition.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are more about how the immune system works rather than the direct effect on graft rejection.",
    "rollout": " These are more about how the immune system works rather than the direct effect on graft rejection. - Option B specifically mentions T-cell maturation resulting in cells that recognize foreign antigens, which directly ties into why the graft is rejected. So putting it together, B is the best answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are more about how the immune system works rather than the direct effect on graft rejection. - Option B specifically mentions T-cell maturation resulting in cells that recognize foreign antigens, which directly ties into why the graft is rejected. So putting it together, B is the best answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "But the main point here is about T-cell activity leading to rejection.",
    "rollout": " But the main point here is about T-cell activity leading to rejection. So focusing on B would be better. Also, understanding that mutations enhance T-cell function in rejecting foreign antigens fits well with what happens after the T-cells have already been formed. So I think the answer is B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). But the main point here is about T-cell activity leading to rejection. So focusing on B would be better. Also, understanding that mutations enhance T-cell function in rejecting foreign antigens fits well with what happens after the T-cells have already been formed. So I think the answer is B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These are part of normal immune responses but don't directly address whether the graft is accepted.",
    "rollout": " These are part of normal immune responses but don't directly address whether the graft is accepted. The main issue here is whether these factors cause rejection. So I think B is the best answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These are part of normal immune responses but don't directly address whether the graft is accepted. The main issue here is whether these factors cause rejection. So I think B is the best answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "These points support the idea that mutation affects T-cell function, leading to rejection.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J).",
    "chunk_resampled": "These all tie into how the immune system works against foreign antigens.",
    "rollout": " These all tie into how the immune system works against foreign antigens. For example, if T-cells have identical receptors, they might have trouble distinguishing self from non-self antigens, making them ineffective. On the other hand, mutating T-cells could change their receptor structure, improving their ability to recognize foreign threats. So these factors indirectly contribute to graft rejection through improved T-cell function. Therefore, the key point is that mutation and recombination enhance T-cell function, specifically by improving their ability to recognize foreign antigens.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These all tie into how the immune system works against foreign antigens. For example, if T-cells have identical receptors, they might have trouble distinguishing self from non-self antigens, making them ineffective. On the other hand, mutating T-cells could change their receptor structure, improving their ability to recognize foreign threats. So these factors indirectly contribute to graft rejection through improved T-cell function. Therefore, the key point is that mutation and recombination enhance T-cell function, specifically by improving their ability to recognize foreign antigens.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  }
]